ArticleTargeted oncology2024

Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes.

Zucheng Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.